These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Debess J, Riis JØ, Engebjerg MC, Ewertz M. Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129 [Abstract] [Full Text] [Related]
7. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700 [Abstract] [Full Text] [Related]
9. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL. Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112 [Abstract] [Full Text] [Related]
10. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K. Cancer; 2008 Nov 01; 113(9):2431-9. PubMed ID: 18823033 [Abstract] [Full Text] [Related]
11. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U. Patient Educ Couns; 2007 Apr 01; 66(1):108-18. PubMed ID: 17320337 [Abstract] [Full Text] [Related]
13. 'Chemobrain' in breast carcinoma?: a prologue. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. Cancer; 2004 Aug 01; 101(3):466-75. PubMed ID: 15274059 [Abstract] [Full Text] [Related]
14. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Psychooncology; 2004 Jan 01; 13(1):61-6. PubMed ID: 14745746 [Abstract] [Full Text] [Related]
15. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C. Psychooncology; 2008 Feb 01; 17(2):122-30. PubMed ID: 17518411 [Abstract] [Full Text] [Related]
16. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Quesnel C, Savard J, Ivers H. Breast Cancer Res Treat; 2009 Jul 01; 116(1):113-23. PubMed ID: 18629633 [Abstract] [Full Text] [Related]
17. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. J Natl Cancer Inst; 2006 Dec 06; 98(23):1742-5. PubMed ID: 17148777 [Abstract] [Full Text] [Related]
18. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial. Maruff P, Falleti MG, Collie A. Cancer; 2004 Nov 01; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092 [No Abstract] [Full Text] [Related]
19. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. Yates P, Aranda S, Hargraves M, Mirolo B, Clavarino A, McLachlan S, Skerman H. J Clin Oncol; 2005 Sep 01; 23(25):6027-36. PubMed ID: 16135471 [Abstract] [Full Text] [Related]
20. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results. Weis J, Poppelreuter M, Bartsch HH. Psychooncology; 2009 Jul 01; 18(7):775-82. PubMed ID: 19061196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]